ABSTRACT
BACKGROUND CONTEXT
PURPOSE
STUDY DESIGN
METHODS
RESULTS
CONCLUSIONS
Key words
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The Spine JournalReferences
- The RAND/UCLA appropriateness method user’s manual.RAND Corporation, Santa Monica, CA2001
- Comparison of minimally invasive fusion and instrumentation versus open surgery for severe stenotic spondylolisthesis with high-grade facet joint osteoarthritis.Eur Spine J. 2013; 22: 1731-1740
- The cost-effectiveness of interbody fusions versus posterolateral fusions in 137 patients with lumbar spondylolisthesis.Spine J. 2015; 15: 492-498
- Degenerative spondylolisthesis does not affect the outcome of unilateral laminotomy with bilateral decompression in patients with lumbar stenosis.Spine. 2014; 39: 400-408
- Results of instrumented posterolateral fusion in treatment of lumbar spondylolisthesis with and without segmental kyphosis: a retrospective investigation.Biomedical J. 2015; 38: 262-268
- Long-term follow-up of minimal-access and open posterior lumbar interbody fusion for spondylolisthesis.Neurosurgery. 2013; 72 (discussion 450-451): 443-450
- Can low-grade spondylolisthesis be effectively treated by either coflex interlaminar stabilization or laminectomy and posterior spinal fusion? Two-year clinical and radiographic results from the randomized, prospective, multicenter US investigational device exemption trial: clinical article.J Neurosurg Spine. 2013; 19: 174-184
- Decompression and Coflex interlaminar stabilization compared with decompression and instrumented spinal fusion for spinal stenosis and low-grade degenerative spondylolisthesis: two-year results from the prospective, randomized, multicenter, Food and Drug Administration Investigational Device Exemption trial.Spine. 2013; 38: 1529-1539
- Imaging characteristics of “dynamic” versus “static” spondylolisthesis: analysis using magnetic resonance imaging and flexion/extension films.Spine J. 2014; 14: 1965-1969
- Sagittal spinopelvic alignment in 654 degenerative spondylolisthesis.Eur Spine J. 2015; 24: 1219-1227
- Does transforaminal lumbar interbody fusion have advantages over posterolateral lumbar fusion for degenerative spondylolisthesis?.Global Spine J. 2015; 5: 102-109
- Decompression and paraspinous tension band: a novel treatment method for patients with lumbar spinal stenosis and degenerative spondylolisthesis.Spine J. 2015; 15: S23-S32
- Posterolateral lumbar arthrodesis with and without interbody arthrodesis for L4-L5 degenerative spondylolisthesis: A comparative value analysis.Spine. 2015; 40: 917-925
- Does bone morphogenetic protein change the operative nonunion rates in spine fusions?.Spine. 2014; 39: 1831-1839
- What types of degenerative lumbar pathologies respond to nerve root injection? A retrospective review of six hundred and forty one cases.Int Orthop. 2015; 39: 1379-1382
- Changes in lumbar spondylolisthesis on axial-loaded MRI: do they reproduce the positional changes in the degree of olisthesis observed on X-ray images in the standing position?.Spine J. 2015; 15: 1255-1262
- Sensitivity of magnetic resonance imaging in the diagnosis of mobile and nonmobile L4-L5 degenerative spondylolisthesis.Spine J. 2015; 15: 1956-1962
- Fusion in degenerative spondylolisthesis: comparison of osteoconductive and osteoinductive bone graft substitutes.Eur Spine J. 2015; 24: 1066-1073
- Hidden spondylolisthesis: unrecognized cause of low back pain? Prospective study about the use of dynamic projections in standing and recumbent position for the individuation of lumbar instability.Neuroradiology. 2015; 57: 583-588
- Lumbar facet joint effusion on MRI as a sign of unstable degenerative spondylolisthesis: should it influence the treatment decision?.J Spinal Disord Tech. 2015; 28: 95-100
- The efficacy of lumbar hybrid stabilization using the DIAM to delay adjacent segment degeneration: an intervention comparison study with a minimum 2-year follow-up.Neurosurgery. 2013; 73 (discussion ons231-232): ons224-ons231
- Complications associated with instrumented lumbar surgery in patients with liver cirrhosis: a matched cohort analysis.Spine J. 2013; 13: 908-913
- Pelvic retroversion is the key protective mechanism of L4-5 degenerative spondylolisthesis.Eur Spine J. 2015; 24: 1204-1211
- Utility of flexion-extension radiographs in lumbar spondylolisthesis.Spine. 2015; 40: E929-E935
- Meta-analysis of circumferential fusion versus posterolateral fusion in lumbar spondylolisthesis.J Spinal Disord Tech. 2014; 27: E282-E293
- Evidence-based surgical management of spondylolisthesis: reduction or arthrodesis in situ (Provisional abstract).JBJS. American volume. 2014; 96: 53-58
- A systematic review with meta-analysis of posterior interbody fusion versus posterolateral fusion in lumbar spondylolisthesis.Eur Spine J. 2014; 23: 43-56
- Posterolateral fusion with interbody for lumbar spondylolisthesis is associated with less repeat surgery than posterolateral fusion alone.Clin Neurol Neurosurg. 2015; 138: 117-123
- The effect of high obesity on outcomes of treatment for lumbar spinal conditions: subgroup analysis of the spine patient outcomes research trial.Spine. 2014; 39: 1975-1980
- Clinical outcomes after microendoscopic laminotomy for lumbar spinal stenosis: a 5-year follow-up study.Eur Spine J. 2015; 24: 396-403
- Relative benefit of TLIF versus PSF stratified by diagnostic indication.J Spinal Disord Tech. 2014; 27: 144-147
- Use of recombinant human bone morphogenetic protein-2 with local bone graft instead of iliac crest bone graft in posterolateral lumbar spine arthrodesis.Spine. 2013; 38: E738-E747
- Two-year comprehensive medical management of degenerative lumbar spine disease (lumbar spondylolisthesis, stenosis, or disc herniation): a value analysis of cost, pain, disability, and quality of life: clinical article.J Neurosurg Spine. 2014; 21: 143-149
- Extent of preoperative depression is associated with return to work after lumbar fusion for spondylolisthesis.World Neurosurg. 2015; 83: 608-613
- Health-related quality of life following decompression compared to decompression and fusion for degenerative lumbar spondylolisthesis: a Canadian multicentre study.Can J Surg. 2014; 57: E126-E133
- Stand-alone anterior lumbar interbody fusion for treatment of degenerative spondylolisthesis.J Clin Neurosci. 2015; 22: 1619-1624
- Effectiveness of surgery for lumbar stenosis and degenerative spondylolisthesis in the octogenarian population: analysis of the Spine Patient Outcomes Research Trial (SPORT) data.J Bone Joint Surg Am. 2015; 97: 177-185
- Reoperation rate and risk factors of elective spinal surgery for degenerative spondylolisthesis: Minimum 5-year follow-up.Spine J. 2015; 15: 1536-1544
- Five-year outcomes of minimally invasive versus open transforaminal lumbar interbody fusion: a matched-pair comparison study.Spine. 2013; 38: 2049-2055
- Minimally invasive versus open transforaminal lumbar interbody fusion for degenerative spondylolisthesis grades 1-2: Patient-reported clinical outcomes and cost-utility analysis.Ochsner J. 2014; 14: 32-37
- The comparison of instrumented and non-instrumented fusion in the treatment of lumbar spondylolisthesis: a meta-analysis.Eur Spine J. 2014; 23: 1918-1926
- The Effect of Smoking on Spinal Fusion.Int J Spine Surg. 2017; 11 (Nov 28): 29
- The effect of cigarette smoking and smoking cessation on spinal fusion.Spine. 2000; 25: 2608-2615
- A cost-effectiveness analysis of smoking-cessation interventions prior to posterolateral lumbar fusion.J Bone Joint Surg Am. 2020; 102: 2032-2042
- Black, white, or gray: how different (or similar) are YODA and the The Spine Journal reviews of BMP-2?.Spine J. 2013; 13: 1001-1005
Coughlan M, Davies M, Mostert AK, Nanda D, Willems PC, Rosenberg G, et al. A Prospective, randomized, multicenter study comparing silicated calcium phosphate versus BMP-2 synthetic bone graft in posterolateral instrumented lumbar fusion for degenerative spinal disorders. 2018;43(15):E860-E868.
- Bone substitutes and expanders in Spine Surgery: a review of their fusion efficacies.Int J Spine Surg. 2016; 10: 33
- Guideline update for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 16: bone graft extenders and substitutes as an adjunct for lumbar fusion.J Neurosurg Spine. 2014; 21: 106-132
- Transforaminal lumbar interbody fusion and posterior lumbar interbody fusion utilizing BMP-2 in treatment of degenerative spondylolisthesis: neither safe nor cost effective.Surg Neurol Int. 2013; 4: S67-S73
- Summary of guidelinmes for the treatment of lumbar spondylolisthesis.Neurosurg Clin North America. 2019; 30: 353-364
- Surgical versus nonsurgical treatment for lumbar degenerative spondylolisthesis.N EngL J Med. 2007; 356: 2257-2270
- Guideline summary review: an evidence-based clinical guideline for the diagnosis and treatment of degenerative lumbar spondylolisthesis.Spine J. 2016; 16: 439-448
- Pidural steroid injections for management of degenerative spondylolisthesis: little effect on clinical outcomes in operatively and nonoperatively treated patients.J Bone Joint Surg Am. 2020; 102: 1297-1304
- The effect of transforaminal epidural steroid injections in patients with spondylolisthesis.J Back Musculoskelet Rehabil. 2017; 30: 841-846
- Jarvik epidural corticosteroid injections for radiculopathy and spinal stenosis: a systematic review and meta-analysis.J.Ann Intern Med. 2015; 163: 373-381
- Three-year follow-up of the prospective, randomized, controlled trial of coflex interlaminar stabilization vs instrumented fusion in patients with lumbar stenosis.Neurosurgery. 2016; 79 (Aug): 169-181
- Predominant leg pain is associated with better surgical outcomes in degenerative spondylolisthesis and spinal stenosis: results from the Spine Patient Outcomes Research Trial (SPORT).Spine. 2011; 36 (Feb 1): 219-229
- Degenerative lumbar spondylolisthesis with spinal stenosis: a prospective, randomized study comparing decompressive laminectomy and arthrodesis with and without spinal instrumentation.Spine. 1997; 22: 2807-2812
- Degenerative lumbar spondylolisthesis with spinal stenosis. A prospective study comparing decompression with decompression and intertransverse process arthrodesis.J Bone Joint Surg Am. 1991; 73: 802-808
- Laminectomy alone versus fusion for grade 1 lumbar spondylolisthesis in 426 patients from the prospective Quality Outcomes Database.J Neurosurg Spine. 2018; 30: 234-241
- Laminectomy plus fusion versus laminectomy alone for lumbar spondylolisthesis.N Engl J Med. 2016; 374: 1424-1434
- Does concomitant degenerative spondylolisthesis influence the outcome of decompression alone in degenerative lumbar spinal stenosis? A meta-analysis of comparative studies.World Neurosurg. 2019; 123: 226-238
- Long-term results of surgery compared with nonoperative treatment for lumbar degenerative spondylolisthesis in the Spine Patient Outcomes Research Trial (SPORT).Spine. 2018; 43: 1619-1630
- Operative management of degenerative spondylolisthesis: a critical analysis review.JBJS Rev. 2018; 6: e4
- Minimally invasive decompression with posterior elements preservation versus laminectomy and fusion for lumbar degenerative spondylolisthesis: a systematic review and meta-analysis of surgical, clinical and radiological outcomes.Surg Technol Int. 2020; 36: 457-463
- The role of fusion and instrumentation in the treatment of degenerative spondylolisthesis with spinal stenosis.J Spinal Disord. 1993; 6: 461-472
- Degenerative lumbar spondylolisthesis with spinal stenosis: a prospective long-term study comparing fusion and pseudarthrosis.Spine. 2004; 29: 726-733
Article info
Publication history
Footnotes
Author disclosures: CAR: Trips/Travel: North American Spine Society (Travel expenses); Scientific Advisory Board: Clinical Orthopedics and Related Research (B, Deputy Editor, paid directly to institution/employer). CHC: Board of Directors: North American Spine Society (Evidence Compilation and Analysis Chair); Other Office: American Society of Neuroradiology (Finance Management Committee Co-chair). CMB: Royalties: Wolters Kluwer (B); Consulting: Harvard Clinical Research Institute (amount not disclosed), United Health Care (B); Board of Directors: North American Spine Society (1st Vice President); Other Office: JAAOS (B). ZG: Board of Directors: American Association of Neurological Surgeons, NeuroPoint Alliance (None), Congress of Neurological Surgeons (Vice President), Collaborative Spine Research Foundation (None), North American Spine Society (Clinical Research Development Chair); Research Support - Staff and/or Materials: Stuart Foundation (F, paid directly to institution/employer); Grants: NIH (A), PCORi (H, Paid directly to institution/employer). JG: Grants: SI Bone (D, Paid directly to institution/employer). CK: Stock Ownership: NOC2 (<1%); Consulting: Hospital Corporation of America (HCA) - TriStar Spine Physician Advisory Panel (amount not disclosed); Trips/Travel: SI Bone (amount not disclosed). DM: Consulting: First Consult (A); Trips/Travel: North American Spine Society (Travel expenses). DO: Nothing to disclose. JO: Royalties: Globus Medical (A), Pioneer Surgical (B); Consulting: Globus Medical (B), Pioneer Surgical (A). HP: Speaking and/or teaching arrangements: PM&R (Senior Editor for PM&R Journal, paid directly to institution/employer); Trips/Travel: North American Spine Society (Travel expenses, paid directly to institution/employer); Board of Directors: North American Spine Society (President). DR: Board of Directors: North American Spine Society (Secretary), CNS (Past President). JS: Nothing to disclose. MJS: Consulting: Inflexxion (A, paid directly to institution/employer). WS: Trips/Travel: North American Spine Society (Travel expenses). RT: Nothing to disclose. ET: Royalties: Stryker Spine (C); Stock Ownership: Doctor's Research Group (<1%); Private Investments: IP Evolutions (None); Board of Directors: North American Spine Society (Administration & Development Council Director); Other Office: AAOS Communications Cabinet (Travel expenses); Research Support - Investigator Salary: Relievant (B, Paid directly to institution/employer); Research Support - Staff and/or Materials: Globus (B, Paid directly to institution/employer); Relationships Outside the One-Year Requirement: Stryker Biotech (None). JW: Royalties: Stryker (A), Osprey (B), Aesculap (B), Biomet (G), Amedica (D), SeaSpine (D), Synthes (C); Stock Ownership: FzioMed (<1%), Alphatec (<1%); Private Investments: Promethean Spine (<1%), Paradigm spine (<1%), Benvenue (<1%), NexGen (<1%), Pioneer (<1%), Amedica (<1%), VertiFlex (<1%), ElectroCore (<1%), Surgitech (<1%), Axiomed (<1%), VG Innovations (<1%), CoreSpine (<1%), Expanding Orthopaedics (<1%), Syndicom (<1%), Osprey (<1%), Amedica (<1%), Bone Biologics (<1%), Curative Biosciences (<1%), PearlDiver (<1%); Board of Directors: North American Spine Society (Treasurer), Cervical Spine Research Society (Travel expenses), AOSpine/AO Foundation (E), Collaborative Spine Research Foundation (None); Fellowship Support: AO Foundation (E, Paid directly to institution/employer). WW: Royalties: Stryker Corporation (B); Board of Directors: North American Spine Society (Past President), World Spine Care (None), American College of Spine Surgeons (None); Other: The Spine Journal (Assistant Editor), Spine Arthroplasty Journal (Assistant Editor), Spine (None), Kirby Glenn Surgical Center (Financial, 1/22nd minority interest ownership). FTW: Stock Ownership: Relievant Medical (<1%); Board of Directors: McKenzie Institute International (B), North American Spine Society (2nd Vice President). GW: Speaking and/or Teaching Arrangements: North American Spine Society (A); Trips/Travel: North American Spine Society (Travel expenses).
Funding Disclosure: No external funding was received for this project.
